What is Pamela Kwena's NPI number?

Pamela Kwena's National Provider Identifier (NPI) is 1003546243, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Pamela Kwena's specialty?

Pamela Kwena is listed in the NPPES registry with a primary specialty of Family Nurse Practitioner (Physician Assistants & Advanced Practice Nursing Providers).

Where is Pamela Kwena located?

Pamela Kwena's practice location on file with NPPES is 1652 Montclair Rd, Irondale, AL 35210-2410.

What is Pamela Kwena's phone number?

The practice phone number listed in the NPPES registry for Pamela Kwena is (205) 956-9192.

Does Pamela Kwena accept Medicare?

Pamela Kwena is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Pamela Kwena's NPI active?

Yes — Pamela Kwena's NPI (1003546243) is active in the NPPES registry as of the last update on 2022-06-11.

IndividualActiveAccepts Medicare

Pamela Kwena

NPI 1003546243 · Family Nurse Practitioner · Irondale, AL

Pamela Kwena is a Family Nurse Practitioner provider in Irondale, AL (NPI 1003546243).

Provider details

NPI number: 1003546243
Entity type: Individual
Primary specialty: Family Nurse PractitionerPhysician Assistants & Advanced Practice Nursing Providers
Sex: Female
Sole proprietor: No
License: 1-152742 (AL)

Practice location

1652 Montclair Rd

Irondale, AL 35210-2410

Phone: (205) 956-9192

Street-level locationGet directions

More AL providers

Mailing address

1652 Montclair Rd

Irondale, AL 35210-2410

Specialties & taxonomies

Family Nurse PractitionerPrimary363LF0000XLicense 1-152742 (AL)
Physician Assistants & Advanced Practice Nursing Providers

Enrolled with Medicare as Practitioner - Nurse Practitioner · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Established profile(63/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
4 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
628 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Detection Test By Immunoassay With Direct Visual Observation for Influenza Virus87804	116	$16
Injection of Drug Or Substance Under Skin Or Into Muscle96372	88	$11
Detection Test By Immunoassay With Direct Visual Observation for Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19)87811	78	$41
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	60	$92
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	57	$69
Detection Test By Immunoassay With Direct Visual Observation for Streptococcus, Group a (strep)87880

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 14 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Azithromycin	88	85
Fluticasone Propionate	73	69
Methylprednisolone	57	57
Doxycycline Hyclate	52	52
Albuterol Sulfatebrand: Albuterol Sulfate Hfa	42	33
Nirmatrelvir/Ritonavirbrand: Paxlovid	39	39
Molnupiravirbrand: Lagevrio (eua)	22	22

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$56 across 1 record (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2022-06-11
Last updated: 2022-06-11
Certified: 2022-06-11

Frequently asked questions

What is Pamela Kwena's NPI number?: Pamela Kwena's National Provider Identifier (NPI) is 1003546243, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Pamela Kwena's specialty?: Pamela Kwena is listed in the NPPES registry with a primary specialty of Family Nurse Practitioner (Physician Assistants & Advanced Practice Nursing Providers).
Where is Pamela Kwena located?: Pamela Kwena's practice location on file with NPPES is 1652 Montclair Rd, Irondale, AL 35210-2410.
What is Pamela Kwena's phone number?: The practice phone number listed in the NPPES registry for Pamela Kwena is (205) 956-9192.
Does Pamela Kwena accept Medicare?: Pamela Kwena is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Pamela Kwena's NPI active?: Yes — Pamela Kwena's NPI (1003546243) is active in the NPPES registry as of the last update on 2022-06-11.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Detection Test By Immunoassay With Direct Visual Observation for Influenza Virus87804	116	$16
Injection of Drug Or Substance Under Skin Or Into Muscle96372	88	$11
Detection Test By Immunoassay With Direct Visual Observation for Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19)87811	78	$41
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	60	$92
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	57	$69
Detection Test By Immunoassay With Direct Visual Observation for Streptococcus, Group a (strep)87880

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 14 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Azithromycin	88	85
Fluticasone Propionate	73	69
Methylprednisolone	57	57
Doxycycline Hyclate	52	52
Albuterol Sulfatebrand: Albuterol Sulfate Hfa	42	33
Nirmatrelvir/Ritonavirbrand: Paxlovid	39	39
Molnupiravirbrand: Lagevrio (eua)	22	22

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$56 across 1 record (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments